发明申请
US20090105245A1 METHODS FOR TREATING MACULAR EDEMA AND OCULAR ANGIOGENESIS USING AN ANTI-INFLAMMATORY AGENT AND A RECEPTOR TYROSINE KINASE INHIBITOR
审中-公开
使用抗炎剂和受体酪氨酸激酶抑制剂治疗乳腺癌和卵巢血管发生的方法
- 专利标题： METHODS FOR TREATING MACULAR EDEMA AND OCULAR ANGIOGENESIS USING AN ANTI-INFLAMMATORY AGENT AND A RECEPTOR TYROSINE KINASE INHIBITOR
- 专利标题（中）： 使用抗炎剂和受体酪氨酸激酶抑制剂治疗乳腺癌和卵巢血管发生的方法
-
申请号： US11962338申请日： 2007-12-21
-
公开(公告)号： US20090105245A1公开(公告)日： 2009-04-23
- 发明人: David P. Bingaman
- 申请人： David P. Bingaman
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; A61K31/423 ; A61K31/416
摘要：
The present invention provides methods for inhibiting increased vascular permeability and/or pathologic ocular angiogenesis via administration of a combination of one or more molecules that potently inhibit select receptor tyrosine kinases (RTKs) or vascular endothelial growth factor (VEGF) and one or more anti-inflammatory agents.
信息查询
IPC分类:
